GSK189075 oral tablets

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Diabetes Mellitus, Type 2Non-Insulin-Dependent Diabetes MellitusType 2 Diabetes Mellitus

Phase 1

Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes

CompletedNCT00376038

GlaxoSmithKlineDiabetes Mellitus, Type 2, Type 2 Diabetes Mellitus

Start: 2006-08-31End: 2006-10-31Updated: 2012-06-04

Phase 2

GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients

CompletedNCT00291356

GlaxoSmithKlineDiabetes Mellitus, Type 2, Non-Insulin-Dependent Diabetes Mellitus

Start: 2006-01-31End: 2006-05-31Updated: 2015-04-15

Related Papers

Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus.

2013-04-3024 citations